Soulaire, based in Santa Monica, CA, is the exclusive distributor of an advanced FDA-cleared EECP device designed to enhance blood circulation. This non-invasive therapy involves applying external pressure to the lower limbs during the diastole phase of the heart cycle, making it a safe and effective option for patients with coronary artery disease or ischemic heart failure.
The Soulaire EECP device has been cleared by the FDA and is recognized for its benefits in improving vasodilation and blood flow. It is particularly intended for patients with chronic stable angina who have not responded to traditional medical therapy or revascularization options. This cutting-edge technology is backed by a legacy of research and development, tracing its origins back to the pioneering work done at Harvard University in the 1950s.
Utilizing a Trinity Pneumatic Delivery System and a treatment mattress, the Soulaire system operates by inflating cuffs around the calves, thighs, and buttocks in sync with the heart's rhythm. This innovative approach effectively reduces the heart's workload and enhances circulation, offering patients a non-surgical therapeutic option for managing cardiovascular conditions.
Generated from the website content